NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced third-quarter 2008 revenue of $573.7 million, up 6 percent or 3 percent year over year on a constant-dollar basis. Net income and EPS grew 33 percent and 41 percent, respectively, in the quarter. After adjusting for certain items, net income rose 11 percent and EPS was up 19 percent (See below and Note c to the financial tables).
